Ergoteles LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$85,919
+90.5%
57,279
+26.9%
0.00%
+50.0%
Q4 2022$45,096
-77.3%
45,150
-59.2%
0.00%
-71.4%
Q3 2022$199,000
-53.4%
110,669
-24.9%
0.01%
-46.2%
Q2 2022$427,000
+284.7%
147,400
+1025.2%
0.01%
+225.0%
Q3 2021$111,00013,1000.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders